ClinicalTrials.gov
public full text
Public Domain
Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study
22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules#875253
- thyme metabolomics profile as a function of origin and sterilization#937356
- Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience#414974
- What a Deletion Certificate Covers, and Where It Expires: Auditable Removal from a Support-Vector Memory#1070875
- Dual action of the innovative thymol-based green bioformulation in storage: control of pest insects and improvement of seed quality#205914
Record · ID 889147
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive